OCUGEN, INC. Operating Income
OCUGEN, INC. (OCGN) reported Operating Income of -$16.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- OCUGEN, INC. operating income (loss) for the quarter ending 2026-06-30 was -$16.44M.
- OCUGEN, INC. operating income (loss) for the quarter ending 2026-03-31 was -$17.84M.
- OCUGEN, INC. operating income (loss) for the quarter ending 2025-12-31 was -$17.00M.
- OCUGEN, INC. operating income (loss) for the quarter ending 2025-09-30 was -$17.63M.
- OCUGEN, INC. operating income (loss) for fiscal 2025 was -$62.92M.
- OCUGEN, INC. operating income (loss) for fiscal 2024 was -$54.76M.
- OCUGEN, INC. operating income (loss) for fiscal 2023 was -$65.53M.
- OCUGEN, INC. operating income (loss) for fiscal 2022 was -$89.07M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$16.44M 10-Q · filed 2026-08-06 | -$34.28M 10-Q · filed 2026-08-06 | -$51.28M derived: sum of 3 quarters · filed 2026-08-06 | -$68.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$17.84M 10-Q · filed 2026-05-08 | -$34.83M derived: sum of 2 quarters · filed 2026-05-08 | -$52.46M derived: sum of 3 quarters · filed 2026-05-08 | -$66.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$34.62M derived: sum of 2 quarters · filed 2026-03-04 | -$48.41M derived: sum of 3 quarters · filed 2026-08-06 | -$62.92M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | -$17.63M 10-Q · filed 2025-11-05 | -$31.42M derived: sum of 2 quarters · filed 2026-08-06 | -$45.92M 10-Q · filed 2025-11-05 | -$59.76M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$13.79M 10-Q · filed 2026-08-06 | -$28.30M 10-Q · filed 2026-08-06 | -$42.14M derived: sum of 3 quarters · filed 2026-08-06 | -$55.39M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$14.50M 10-Q · filed 2026-05-08 | -$28.34M derived: sum of 2 quarters · filed 2026-05-08 | -$41.59M derived: sum of 3 quarters · filed 2026-05-08 | -$57.04M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$13.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$27.09M derived: sum of 2 quarters · filed 2026-03-04 | -$42.54M derived: sum of 3 quarters · filed 2026-03-04 | -$54.76M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | -$13.25M 10-Q · filed 2025-11-05 | -$28.70M derived: sum of 2 quarters · filed 2025-11-05 | -$40.92M 10-Q · filed 2025-11-05 | -$52.44M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$15.45M 10-Q · filed 2025-08-04 | -$27.66M 10-Q · filed 2025-08-04 | -$39.19M derived: sum of 3 quarters · filed 2025-08-04 | -$51.62M derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-03-31 | -$12.22M 10-Q · filed 2025-05-09 | -$23.74M derived: sum of 2 quarters · filed 2025-05-09 | -$36.17M derived: sum of 3 quarters · filed 2025-05-09 | -$59.71M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | -$11.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$23.96M derived: sum of 2 quarters · filed 2025-03-05 | -$47.50M derived: sum of 3 quarters · filed 2025-03-05 | -$65.53M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | -$12.43M 10-Q · filed 2024-11-14 | -$15.42M 10-Q · filed 2023-11-09 | -$35.97M derived: sum of 2 quarters · filed 2024-11-14 | -$54.01M 10-Q · filed 2024-11-14 | -$56.91M 10-Q · filed 2023-11-09 | -$77.36M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$23.54M 10-Q · filed 2024-08-08 | -$23.73M 10-Q · filed 2023-08-21 | -$41.58M 10-Q · filed 2024-08-08 | -$41.48M 10-Q · filed 2023-08-21 | -$64.93M derived: sum of 3 quarters · filed 2024-08-08 | -$90.04M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$18.04M 10-Q · filed 2024-05-14 | -$17.75M 10-Q · filed 2023-05-05 | -$41.39M derived: sum of 2 quarters · filed 2024-05-14 | -$66.50M derived: sum of 3 quarters · filed 2024-05-14 | -$88.08M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$23.36M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | -$48.47M derived: sum of 2 quarters · filed 2024-04-16 | -$70.04M derived: sum of 3 quarters · filed 2024-04-16 | -$89.07M 10-K · filed 2024-04-16 | -$84.87M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$25.11M 10-K · filed 2024-04-16 | -$23.12M 10-Q · filed 2022-11-08 | -$46.69M derived: sum of 2 quarters · filed 2024-04-16 | -$65.72M 10-K · filed 2024-04-16 | -$60.72M 10-Q · filed 2022-11-08 | -$80.29M derived: sum of 4 quarters · filed 2024-04-16 | ||
| 2022-06-30 | -$21.58M 10-K · filed 2024-04-16 | -$19.57M 10-Q · filed 2022-08-05 | -$40.61M 10-K · filed 2024-04-16 | -$37.60M 10-Q · filed 2022-08-05 | -$55.18M derived: sum of 3 quarters · filed 2024-04-16 | -$65.97M derived: sum of 4 quarters · filed 2024-04-16 | ||
| 2022-03-31 | -$19.03M 10-K · filed 2024-04-16 | -$18.03M 10-Q · filed 2022-05-06 | -$33.60M derived: sum of 2 quarters · filed 2024-04-16 | -$44.39M derived: sum of 3 quarters · filed 2024-04-16 | -$70.00M derived: sum of 4 quarters · filed 2024-04-16 | |||
| 2021-12-31 | -$14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$25.36M derived: sum of 2 quarters · filed 2023-02-28 | -$50.97M derived: sum of 3 quarters · filed 2023-02-28 | -$58.03M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | -$10.79M 10-Q · filed 2022-11-08 | -$36.40M derived: sum of 2 quarters · filed 2022-11-08 | -$43.46M 10-Q · filed 2022-11-08 | -$47.26M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$25.61M 10-Q · filed 2022-08-05 | -$32.67M 10-Q · filed 2022-08-05 | -$36.48M derived: sum of 3 quarters · filed 2022-08-05 | -$46.66M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | -$7.06M 10-Q · filed 2022-05-06 | -$10.87M derived: sum of 2 quarters · filed 2022-05-06 | -$21.05M derived: sum of 3 quarters · filed 2022-05-06 | -$24.41M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$13.99M derived: sum of 2 quarters · filed 2022-02-28 | -$17.36M derived: sum of 3 quarters · filed 2022-02-28 | -$21.29M 10-K · filed 2022-02-28 | -$21.28M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | -$10.18M 10-Q · filed 2021-11-09 | -$10.18M 10-Q · filed 2020-11-06 | -$13.55M derived: sum of 2 quarters · filed 2021-11-09 | -$17.48M 10-Q · filed 2021-11-09 | -$17.48M 10-Q · filed 2020-11-06 | -$21.76M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | -$3.37M 10-Q · filed 2021-08-06 | -$3.37M 10-Q · filed 2020-08-14 | -$7.29M 10-Q · filed 2021-08-06 | -$7.30M 10-Q · filed 2020-08-14 | -$11.57M derived: sum of 3 quarters · filed 2022-02-28 | -$14.29M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | -$3.93M 10-Q · filed 2021-05-07 | -$3.93M 10-Q · filed 2020-05-08 | -$8.21M derived: sum of 2 quarters · filed 2022-02-28 | -$10.92M derived: sum of 3 quarters · filed 2022-02-28 | -$13.25M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | -$4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$6.99M derived: sum of 2 quarters · filed 2022-02-28 | -$9.32M derived: sum of 3 quarters · filed 2022-02-28 | -$14.16M 10-K · filed 2022-02-28 | -$14.16M 10-K · filed 2020-03-27 | |||
| 2019-09-30 | -$2.71M 10-Q · filed 2020-11-06 | -$5.04M derived: sum of 2 quarters · filed 2020-11-06 | -$9.88M 10-Q · filed 2020-11-06 | -$15.57M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$2.33M 10-Q · filed 2020-08-14 | -$3.06M 10-Q · filed 2019-08-09 | -$7.17M 10-Q · filed 2020-08-14 | -$11.11M 10-Q · filed 2019-08-09 | -$12.86M derived: sum of 3 quarters · filed 2020-08-14 | -$15.26M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | -$4.84M 10-Q · filed 2020-05-08 | -$8.05M 10-Q · filed 2019-05-15 | -$10.53M derived: sum of 2 quarters · filed 2020-05-08 | -$12.93M derived: sum of 3 quarters · filed 2020-05-08 | -$16.99M derived: sum of 4 quarters · filed 2020-05-08 | |||
| 2018-12-31 | -$5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$8.09M derived: sum of 2 quarters · filed 2020-03-27 | -$12.15M derived: sum of 3 quarters · filed 2020-03-27 | -$16.14M 10-K · filed 2020-03-27 | -$30.11M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | -$2.40M 10-Q · filed 2019-11-12 | -$6.99M 10-Q · filed 2018-11-08 | -$6.46M derived: sum of 2 quarters · filed 2019-11-12 | -$10.45M 10-Q · filed 2019-11-12 | -$20.37M 10-Q · filed 2018-11-08 | -$18.58M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$4.05M 8-K/A · filed 2019-10-07 | -$7.28M 10-Q · filed 2018-08-09 | -$8.05M 8-K/A · filed 2019-10-07 | -$13.38M 10-Q · filed 2018-08-09 | -$16.18M derived: sum of 3 quarters · filed 2019-10-07 | -$21.89M derived: sum of 4 quarters · filed 2019-10-07 | ||
| 2018-03-31 | -$6.09M 10-Q · filed 2019-05-15 | -$12.13M derived: sum of 2 quarters · filed 2019-05-15 | -$17.84M derived: sum of 3 quarters · filed 2019-05-15 | -$24.21M derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$11.75M derived: sum of 2 quarters · filed 2019-03-22 | -$18.12M derived: sum of 3 quarters · filed 2019-03-22 | -$24.95M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$5.71M 10-Q · filed 2018-11-08 | -$12.09M derived: sum of 2 quarters · filed 2018-11-08 | -$18.92M 10-Q · filed 2018-11-08 | -$26.82M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$6.37M 10-Q · filed 2018-08-09 | -$13.20M 10-Q · filed 2018-08-09 | -$21.11M derived: sum of 3 quarters · filed 2018-08-09 | -$27.76M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$6.83M 10-Q · filed 2018-05-10 | -$14.74M derived: sum of 2 quarters · filed 2018-05-10 | -$21.38M derived: sum of 3 quarters · filed 2018-05-10 | -$29.34M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$14.55M derived: sum of 2 quarters · filed 2018-03-15 | -$22.51M derived: sum of 3 quarters · filed 2018-03-15 | -$30.31M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | -$6.65M 10-Q · filed 2017-11-09 | -$14.60M derived: sum of 2 quarters · filed 2017-11-09 | -$22.40M 10-Q · filed 2017-11-09 | -$30.71M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | -$7.96M 10-Q · filed 2017-08-10 | -$15.75M 10-Q · filed 2017-08-10 | -$24.07M derived: sum of 3 quarters · filed 2017-08-10 | -$32.11M derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | -$7.80M 10-Q · filed 2017-05-11 | -$16.11M derived: sum of 2 quarters · filed 2017-05-11 | -$24.15M derived: sum of 3 quarters · filed 2017-05-11 | -$31.74M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | -$8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$16.35M derived: sum of 2 quarters · filed 2017-03-16 | -$23.95M derived: sum of 3 quarters · filed 2017-03-16 | -$31.82M 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | -$8.04M 10-Q · filed 2016-11-10 | -$15.63M derived: sum of 2 quarters · filed 2016-11-10 | -$23.50M 10-Q · filed 2016-11-10 | -$30.04M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | -$7.59M 10-Q · filed 2016-08-11 | -$15.47M 10-Q · filed 2016-08-11 | -$22.00M derived: sum of 3 quarters · filed 2016-08-11 | -$36.95M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | -$7.87M 10-Q · filed 2016-05-12 | -$14.41M derived: sum of 2 quarters · filed 2016-05-12 | -$29.35M derived: sum of 3 quarters · filed 2016-05-12 | -$35.36M derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | -$6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$21.48M derived: sum of 2 quarters · filed 2016-03-10 | -$27.49M derived: sum of 3 quarters · filed 2016-03-10 | -$32.66M 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | -$14.94M 10-Q · filed 2015-11-12 | -$20.95M derived: sum of 2 quarters · filed 2015-11-12 | -$26.12M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$6.01M 10-Q · filed 2015-08-12 | -$11.18M 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | -$5.17M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |